Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Flyvbjerg

Showing results (171-180 of 253) with videos related to

Pageof 26
Sort By:
Scandinavian Journal of Immunology|January 29, 2013
Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetesJ A Ostergaard, M Bjerre, F Dagnaes-Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1988
Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patientsJ O Jørgensen, A Flyvbjerg, T Lauritzen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 27, 2000
GH decreases hepatic amino acid degradation after small bowel resection in rats without enhancing bowel adaptationK Ljungmann, T Grofte, P Kissmeyer-Nielsen, et al.
Bone|July 12, 2002
Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1G Schmidmaier, B Wildemann, J Heeger, et al.
Transplantation Proceedings|June 1, 1995
Growth hormone and insulin-like growth factor-I: a suggested role in renal transplantation and graft vessel diseaseH Grønbaek, C Skjaerbaek, B Nielsen, et al.
Diabetes & Metabolism|September 19, 2016
Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndromeS Lindberg, J S Jensen, M Bjerre, et al.
Kidney International|April 1, 1992
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretionA Flyvbjerg, S M Marshall, J Frystyk, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 18, 2003
Zinc ions in beta-cells of obese, insulin-resistant, and type 2 diabetic rats traced by autometallographyL G Søndergaard, M Stoltenberg, A Flyvbjerg, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 20, 1999
Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in ratsC Skjaerbaek, J Frystyk, T Grøfte, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysisR K Støving, A Flyvbjerg, J Frystyk, et al.
Pageof 26

Showing results (171-180 of 253) with videos related to

Sort By:
Pageof 26
Scandinavian Journal of Immunology|January 29, 2013
Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetesJ A Ostergaard, M Bjerre, F Dagnaes-Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1988
Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patientsJ O Jørgensen, A Flyvbjerg, T Lauritzen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 27, 2000
GH decreases hepatic amino acid degradation after small bowel resection in rats without enhancing bowel adaptationK Ljungmann, T Grofte, P Kissmeyer-Nielsen, et al.
Bone|July 12, 2002
Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1G Schmidmaier, B Wildemann, J Heeger, et al.
Transplantation Proceedings|June 1, 1995
Growth hormone and insulin-like growth factor-I: a suggested role in renal transplantation and graft vessel diseaseH Grønbaek, C Skjaerbaek, B Nielsen, et al.
Diabetes & Metabolism|September 19, 2016
Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndromeS Lindberg, J S Jensen, M Bjerre, et al.
Kidney International|April 1, 1992
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretionA Flyvbjerg, S M Marshall, J Frystyk, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 18, 2003
Zinc ions in beta-cells of obese, insulin-resistant, and type 2 diabetic rats traced by autometallographyL G Søndergaard, M Stoltenberg, A Flyvbjerg, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 20, 1999
Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in ratsC Skjaerbaek, J Frystyk, T Grøfte, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysisR K Støving, A Flyvbjerg, J Frystyk, et al.
Pageof 26